Efficacy of remibrutinib in anti-IgE biologic-naïve, biologic-experienced, and biologic-refractory patients with CSU: REMIX-1/-2 studies

Sarbjit Saini, Giselle Mosnaim, Gordon Sussman, Martin Metz, Sibylle Haemmerle, Karine Lheritier, Bin Yang, Noriko Seko, Pengpeng Wang, Atsushi Fukunaga

Oral Presentation

Effect of remibrutinib on sleep and daily activities in patients with chronic spontaneous urticaria (CSU) up to week 52 in the REMIX-1/-2 studies

Robert Snyder, Yang Bin, Dawn Merritt, Simon F Thomsen, Atsushi Fukunaga, Clarice Field, Sibylle Haemmerle, Chia-Ya Chu, Noriko Seko, Martin Metz

Oral Presentation

Early and sustained efficacy of remibrutinib in adult patients with CSU: Pooled analysis of REMIX‑1/-2

Shaila Gogate, Michael Palumbo, Ana Maria Giménez-Arnau, Shiqin Tao, Michihiro Hide, Karine Lheritier, Paula Machado, Knut Brockow

Oral Presentation

Remibrutinib-treated patients with CSU who achieve well-controlled disease activity reach this by week 3 in the majority of patients: Results from REMIX-1/-2 studies

Martin Metz, Michihiro Hide, Wei Lai, Sibylle Haemmerle, Nadine Chapman-Rothe, Christine-Elke Ortmann, Giselle Mosnaim

Oral Presentation

Efficacy of remibrutinib in patients with CSU by demographics and baseline characteristics: Pooled analysis from REMIX-1/-2 studies

Sarbjit Saini, Atsushi Fukunaga, Bin Yang, Sibylle Haemmerle, El-Djouher Martzloff, Christine-Elke Ortmann, Karine Lheritier, Vipul Jain

Poster (Guided Poster Walk)

Urticaria Voices China: A real-world study design to assess the perspectives of Chinese patients and physicians on the burden and treatment of chronic urticaria

Zhao Zuotao, Li Yi, Tara Raftery, Nadine Chapman-Rothe, Pallavi Saraswat, Jessica McCarthy, Ravneet Kaur Kohli, Panagiotis Orfanos, Cristina Constantinescu, Angie Li, Guojiao You, Ruixin Tan, Bin Yang

Poster (Guided Poster Walk)

Urticaria Voices (China): A survey on physicians’ perception of chronic urticaria and its treatment in China

Zhao Zuotao, Li Yi, Tara Raftery, Nadine Chapman-Rothe, Pallavi Saraswat, Jessica McCarthy, Ravneet Kaur Kohli, Panagiotis Orfanos, Cristina Constantinescu, Angie Li, Guojiao You, Ruixin Tan, Bin Yang

Poster (Guided Poster Walk)

Remibrutinib improves urticaria symptoms, quality of life and sleep: An analysis from REMIX-1/-2 studies

Mark Lebwohl, Vipul Jain, Michihiro Hide, Hao Cheng, Petra Staubach-Renz, Sibylle Haemmerle, Christine-Elke Ortmann, El-Djouher Martzloff, Karine Lheritier, Hugh Windom

Poster

The impact of remibrutinib on urticaria control in patients with chronic spontaneous urticaria: Long-term results from the REMIX-1/-2 phase 3 trials

Martin Metz, Yang Bin, Eric Boren, Hidetoshi Takahashi, Sabine Altrichter, Pengpeng Wang, Karine Lheritier, El-Djouher Martzloff, Sibylle Haemmerle, Sarbjit Saini

Poster

Remibrutinib treatment has no clinical impact on mean blood cell counts in patients with chronic spontaneous urticaria: Pooled safety analysis from REMIX-1 and REMIX-2 studies

Giselle Mosnaim, Hugh Windom, Gao Xinghua, Martin Metz, Sarbjit Saini, Atsushi Fukunaga, Alis Burciu, Songqiao Huang, Karine Lheritier, Hichem Zouater, Sibylle Haemmerle, Ana Giménez-Arnau

Poster

Remibrutinib demonstrates sustained control of angioedema in patients with chronic spontaneous urticaria: 52-week treatment results from the phase 3 REMIX studies

Michihiro Hide, Petra Staubach, Abdallah Khemis, Vipul Jain, Wang Huiping, Shaila Gogate, El-Djouher Martzloff, Sibylle Haemmerle, Christine-Elke Ortmann, Nadine Chapman-Rothe, Mark Lebwohl

Poster

Remibrutinib improves chronic spontaneous urticaria independent of baseline immunoglobulin E levels in the phase 3 REMIX studies

John Reed, Mark Lebwohl, Vipul Jain, Hugh Windom, Xian Jiang, Noriko Seko, Pengpeng Wang, Sibylle Haemmerle, Ana Giménez-Arnau

Poster

Improvement across work productivity and quality of life with remibrutinib treatment in patients with chronic spontaneous urticaria in the REMIX-1/2 trials

Sinisa Savic, John Reed, Tariq El-Shanawany, Paula G.P. Machado, Noriko Seko, Pengpeng Wang, Claire Field, Ana M. Giménez-Arnau

Poster

Impact of remibrutinib treatment on disease activity status and Dermatology Life Quality Index (DLQI) subdomains in patients with chronic spontaneous urticaria in the REMIX-1/-2 studies

Sinisa Savic, John Reed, Tariq El-Shanawany, Nadine Chapman-Rothe, Paula G. P. Machado, Christine Elke Ortmann, Elodie Incera, Claire Field, Ana Giménez-Arnau, Sarbjit Saini

Poster

Prescribing patterns and treatment outcome of dermatologists and allergists for chronic spontaneous urticaria: Urticaria Voices study

Jonathan A. Bernstein, Tonya A. Winders, Jessica McCarthy, Pallavi Saraswat, Merin Kalangara, Dhaval Patil, Nadine Chapman-Rothe, Tara Raftery, Karsten Weller

Poster

Out-of-pocket expenses in patients with chronic spontaneous urticaria: Results from Urticaria Voices

Tonya A. Winders, Jonathan A. Bernstein, Tara Raftery, Nadine Chapman-Rothe, Jessica McCarthy, Pallavi Saraswat, Panagiotis Orfanos, Ravneet Kaur Kohli, Dhaval Patil, Karsten Weller

Poster

Patient journey and disease burden in chronic inducible urticaria (CIndU): Analysis from the Urticaria Voices study

Sabine Altrichter, Giselle Mosnaim, Jonathan A. Bernstein, Tonya A. Winders, Jessica McCarthy, Pallavi Saraswat, Nadine Chapman-Rothe, Tara Raftery, Karsten Weller

Poster